Xcout Intel
Asceneuron
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Subscribe to see Asceneuron’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Asceneuron at a glance
Asceneuron is a biotechnology company headquartered in Switzerland, founded in 2012. It has raised at least $130.7M across the 2 funding rounds on record. Its most recent funding round, Series C, raised $100M in July 2024. Xcout tracks 1 named person at Asceneuron, including Abbas Hussain (Chair).
Asceneuron leadership
- Abbas HussainChair
Asceneuron funding rounds
At least $130.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $100M | 8 named | |
| Grant | $30.7M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Asceneuron competitors
A few of Asceneuron's closest competitors — see the full list of competitors and alternatives →
Argo Therapeutics is a Swiss biotechnology company headquartered in Allschwil, Switzerland, focused on neurodegenerative-disease therapeutics.
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on discovering and developing novel treatments for neurological conditions and spinal cord injuries. Founded in 2019, the company advances therapeutic candidates through its proprietary research platform.
Aspen Neuroscience, Inc. is a clinical-stage private biotechnology company headquartered in San Diego, California. The company focuses on developing personalized autologous cell therapies for neurodegenerative diseases.
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to treat neurodegenerative diseases by targeting specific receptor systems in the brain. The company's scientific approach focuses on restoring neurovascular and neuronal function to serve patients suffering from conditions such as Parkinson's disease and other neurodegenerative disorders.
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Get Asceneuron's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Asceneuron in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access